[The use of sugammadex in a patient with myasthenia gravis].
A
A
Challan Belval
G
G
Tramoni
J-M
JM
Vedrinne
E
E
Olagne
M
M
Vigneron
D000368:Aged; D000732:Androstanols / Q000037:antagonists & inhibitors; D000768:Anesthesia, General; D002800:Cholinesterase Inhibitors; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal; D009157:Myasthenia Gravis / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D019148:Neuromuscular Blockade; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D000077123:Rocuronium; D000077122:Sugammadex; D013934:Thymectomy; D013965:Thyroidectomy; D047408:gamma-Cyclodextrins
D000732:Androstanols; D002800:Cholinesterase Inhibitors; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D011729:Pyridostigmine Bromide; D000077123:Rocuronium